Mot‐2 is a potent oncoprotein that is upregulated in many cancers, including human colorectal cancer (Black and Rezvani, 2016; Dundas et al., 2005; Gestl and Anne Bottger, 2012; Pilzer et al., 2010; Rozenberg et al., 2013). Here, HSPA9 is linked to cancer.